AI-powered medicines could pave way to new treatments for Parkinson’s and MND

AI-designed intrabodies could help target disease-linked proteins inside cells, with potential applications in Parkinson's, MND and Alzheimer's treatments. The microscopic antibody fragments are designed to remain stable inside human cells, where they can attach to proteins associated with neurodegenerative conditions. Researchers used artificial intelligence and protein redesign techniques to…